Product

Images of Additional Products

All flavors of Diamond Shruumz-brand products have been recalled:

• Microdosing Chocolate Bars
• Infused Cones
• Micro-Dose and Mega-Dose/Extreme Gummies

Symptoms

People who became ill after eating Diamond Shruumz-brand products reported a variety of severe symptoms including seizures, central nervous system depression (loss of consciousness, confusion, sleepiness), agitation, abnormal heart rates, hyper/hypotension, nausea, and vomiting.

Stores Affected

Diamond Shruumz-brand products have been recalled and should no longer be available for sale. These products were available online and in person at a variety of retail locations nationwide including smoke/vape shops, and at retailers that sell hemp-derived products such as cannabidiol (CBD) or delta-8 tetrahydrocannabinol (delta-8 THC).

FDA is aware that, as of July 16, recalled Diamond Shruumz-brand products were still available for sale at several smoke/vape shops, and at retailers that sell hemp-derived products such as cannabidiol (CBD) or delta-8 tetrahydrocannabinol (delta-8 THC). All Diamond Shruumz-brand products have been recalled and should not be sold. Consumers should not purchase any Diamond Shruumz-brand products. If you have seen a store continuing to sell recalled Diamond Shruumz-brand product, you can report this information to FDA.

Status

Ongoing. Updates to this advisory will be provided as they become available.

Recommendation

• Consumers should not buy or eat any flavor of Diamond Shruumz-brand Chocolate Bars, Cones, or Gummies.
• Consumers should check their homes and discard these products or return them to the company for a refund.
• These products may appeal to children and teenagers. Parents and caregivers should consider discussing the information in this advisory with their children and take extra care to avoid these products being consumed by younger people.
• Retailers should not sell or distribute any flavor of Diamond Shruumz-brand Chocolate Bars, Cones, or Gummies, and should hold the product in a secure location and contact the recalling company to initiate the return and refund.
• If you become ill after consuming these products, please contact your healthcare provider and/or call the Poison Help Line at 1-800-222-1222. Let them know you have recently consumed the Diamond Shruumz-brand Chocolate Bars, Cones, and/or Gummies.
• Healthcare providers should report these illnesses to their local health department and/or the Poison Help Line.

Current Update

July 16, 2024

As of July 15, 2024, a total of 69 illnesses have been reported from 28 states. Sixty (60) of the 69 people have reported seeking medical care, 36 have been hospitalized, and there is one potentially associated death under investigation.

FDA is aware that recalled Diamond Shruumz-brand products are still on the shelves at several smoke/vape shops, and at retailers that sell hemp-derived products such as cannabidiol (CBD) or delta-8 tetrahydrocannabinol (delta-8 THC). FDA is monitoring the firm’s recall to assess its effectiveness. 

FDA is working with the National Association of Convenience Stores and the National Smoke Shop Association to increase awareness of the recall. All Diamond Shruumz-brand products have been recalled and should not be available for sale. Consumers should not purchase or consume any Diamond Shruumz-brand products. If you have seen a store continuing to sell recalled Diamond Shruumz-brand products, you can report this information to FDA. 

This advisory will be updated as additional information becomes available.

Product Images

Previous Update

July 9, 2024

As of July 8, 2024, a total of 58 illnesses have been reported from 27 states. 50 of the 58 people have reported seeking medical care, 30 have been hospitalized, and there is one potentially associated death under investigation.

This advisory will be updated as additional information becomes available.

July 2, 2024

As of July 1, 2024, a total of 48 illnesses have been reported from 24 states including AL (1), AZ (6), CA (1), CO (1), FL (1), GA (3), IN (5), IA (3), KY (3), MD (1), MN (1), MO (1), MT (1), NV (1), NJ (2), NY (1), NC (3), ND (1), OH (2), OK (1), PA (2), SC (4), SD (1), and TN (2). Forty-six (46) of the 48 people have reported seeking medical care; Twenty-seven (27) have been hospitalized. There is one (1) potentially associated death under investigation.

This advisory will be updated as additional information becomes available.

June 28, 2024

The FDA and CDC, in collaboration with America’s Poison Centers and state and local partners, are investigating a series of illnesses associated with eating Diamond Shruumz-brand Chocolate Bars, Cones, and Gummies. 

On June 27, 2024, Prophet Premium Blends, LLC of Santa Ana, CA, initiated a recall of all flavors of Diamond Shruumz-brand Chocolate Bars, Cones, and Gummies. According to the firm, these products contain muscimol, a chemical found in some mushrooms, that could be a potential cause of symptoms consistent with some symptoms observed in individuals who became ill after consuming Diamond Shruumz-brand products. FDA is evaluating this information.

As previously reported, FDA and state partners have collected multiple samples of Diamond Shruumz-brand products for testing and analysis. Additional sample analysis is ongoing, but as of June 25, 2024 test results for two individual chocolate bars collected from a retail store have identified the presence of the following:

• Diamond Shruumz Dark Chocolate Bar
  • 4-acetoxy-N,N-dimethyltryptamine (4-acetoxy-DMT, also known as O-acetylpsilocin or psilacetin)
  • desmethoxyyangonin
  • dihydrokavain
  • kavain
• Diamond Shruumz Birthday Cake Chocolate Bar
  • 4-acetoxy-N,N-dimethyltryptamine (4-acetoxy-DMT, also known as O-acetylpsilocin or psilacetin)

There may be variability in test results across products with different formulations as well as potential variability across lots and batches of the same product. Additional testing for the above Diamond Shruumz-brand Chocolate Bars, along with testing for other Diamond Shruumz-brand products, is in progress. FDA and CDC medical officers are interpreting these test results to understand the health risks of ingesting these chemical substances and to determine the appropriate next steps. 

This advisory will be updated as additional information becomes available. 

June 25, 2024

The FDA and CDC, in collaboration with America’s Poison Centers and state and local partners, are investigating a series of illnesses associated with eating Diamond Shruumz-brand Chocolate Bars, Cones, and Gummies. 

FDA has been in contact with the firm about a possible voluntary recall, but to date, the firm has not initiated the recall.

As part of this investigation, FDA and state partners have collected multiple samples of Diamond Shruumz-brand products for testing and analysis. Additional sample analysis is ongoing, but as of June 25, 2024 test results for two individual chocolate bars collected from a retail store have identified the presence of the following:

• Diamond Shruumz Dark Chocolate Bar
  • 4-acetoxy-N,N-dimethyltryptamine (4-acetoxy-DMT, also known as O-acetylpsilocin or psilacetin)
  • desmethoxyyangonin
  • dihydrokavain
  • kavain
• Diamond Shruumz Birthday Cake Chocolate Bar
  • 4-acetoxy-N,N-dimethyltryptamine (4-acetoxy-DMT, also known as O-acetylpsilocin or psilacetin)

There may be variability in test results across products with different formulations as well as potential variability across lots and batches of the same product. Additional testing for the above Diamond Shruumz-brand Chocolate Bars, along with testing for other Diamond Shruumz-brand products, is in progress. FDA and CDC medical officers are interpreting these test results to understand the health risks of ingesting these chemical substances and to determine the appropriate next steps. 

This advisory will be updated as additional information becomes available. 

June 18, 2024

The FDA and CDC, in collaboration with America’s Poison Centers and state and local partners, are investigating a series of illnesses associated with eating Diamond Shruumz-brand Chocolate Bars, Cones, and Gummies.

As part of this investigation, FDA and state partners have collected multiple samples of Diamond Shruumz-brand Chocolate Bars and the analysis is ongoing. FDA's investigation is ongoing to determine the cause of these illnesses and the appropriate next steps.

As of June 17, 2024, a total of 26 illnesses have been reported from 16 states including AL (1), AZ (6), CA (1), IN (3), KY (2), MD (1), MN (1), MO (1), MT (1), NV (1), NJ (1), NY (1), NC (1), PA (1), SC (3), and TN (1). Twenty-five (25) of the 26 people have reported seeking medical care; 16 have been hospitalized. No deaths have been reported.

FDA has been in contact with the firm about a possible voluntary recall, but these discussions are still ongoing. This advisory will be updated as additional information becomes available.

June 11, 2024

The FDA and CDC, in collaboration with America’s Poison Centers and state and local partners, are investigating a series of illnesses associated with eating Diamond Shruumz-brand Chocolate Bars, Cones, and Gummies. 

As of June 10, 2024, additional Diamond Shruumz-brand products have been reported by people who became ill, including the Diamond Shruumz-brand Chocolate Bars, Cones, and Gummies. A total of 12 illnesses have been reported from eight states including AL (1), AZ (4), IN (2), KY (1), MO (1), NV (1), PA (1), and SC (1). All 12 people have reported seeking medical care; 10 have been hospitalized. No deaths have been reported. FDA is working to determine the cause of these illnesses and is considering the appropriate next steps. More information will be provided as it becomes available.

June 7, 2024

The FDA and CDC, in collaboration with America’s Poison Centers and state and local partners, are investigating a series of illnesses associated with eating Diamond Shruumz-brand Microdosing Chocolate Bars. 

As of June 7, 2024, a total of eight illnesses have been reported from four states including AZ (4), IN (2), NV (1), and PA (1). All eight people have reported seeking medical care; six have been hospitalized. No deaths have been reported. FDA is working to determine the cause of these illnesses and is considering the appropriate next steps. More information will be provided as it becomes available.